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Background: The understanding of the relationship between comorbidities, nutritional status, and
cognitive manifestations in depression is limited. This study investigated and compared the association
between comorbidity status, nutritional status, and neuropsychological performance in depressed and
nondepressed community-dwelling older adults.
Methods: This cross-sectional study recruited 318 elderly people aged 60 years and above from 15 low-cost
public residential buildings located in the Cheras area, Malaysia. Structured in-person questionnaireswere
administered to obtain information regarding demographic, socioeconomic, and psychosocial character-
istics. The GDS-15 Geriatric Depression Scale was used to measure depressive symptomatology with
a threshold of 4/5. Comorbidity status was conﬁrmed by examination of medical records. Indication of
nutritional status included anthropometric measurements, nutritional intake assessments, and
biochemical analyses. Comprehensive neuropsychological assessments were conducted to assess cogni-
tive function. All tested parameters were compared with the symptoms of depression.
Results: The prevalence of depressive symptoms was 30.2%. Subjects who were lacking habitual exercise
were two-fold more likely to have symptoms of depression (adjusted odds ratio: 2.163; 95% conﬁdence
interval: 1.236e3.788; p< 0.01). Depressed and nondepressedpatients had the same trends in comorbidity
status, and no signiﬁcant differenceswere noted between the groups on anyof the nutritional assessments.
However, depressed patients had poorer global cognitive functions (F ¼ 4.740, p < 0.05) and verbal
immediate verbal learning and memory (F ¼ 4.113, p < 0.05) compared with the nondepressed patients.
Conclusion: This study found that less exercise is an independent predictor of depressive symptom-
atology. Cognition-enhancing interventions are needed for the at-risk elderly with depressive symptoms
in order to prevent the progression to severe depression.
Copyright  2012, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
Depression ranks equal to Alzheimer’s disease (AD) as the most
urgent geriatric neuropsychiatric disorder in the coming 21st
century. Accumulating evidence shows that depression in elderly
people may have a more adverse trajectory than in younger
people1, as they have greater worries and medical comorbidities,
lack psychological and social support, and a diminution in close
social contacts2. Moreover, depression in old age is a multifaceted
disorder that may affect not only mood regulation, but alsoerest.
ogram, School of Health Care
angsaan Malaysia, Jalan Raja
har).
iwan Society of Geriatric Emergencognition, brain structure, and personality3. Arising from the steep
enrichment of medical services, human life expectancy is longer
compared with the last several decades, and this increases the
government’s burden to provide better healthcare services. Hence,
early identiﬁcation of elders who are at greater risk of developing
clinically signiﬁcant depression is of greatest importance.
Thereare anumberofunknownsandgaps inwhatweunderstand
about depression among elderly people. First, investigations on the
inﬂuence of comorbidity status on depressive symptoms in the late
life are limited, andmost were conducted inWestern and developed
countries among populations of psychiatric inpatients and outpa-
tients4,5. Limited numbers of depression studies have been con-
ducted in the community setting as opposed to clinical and primary
care settings6. Because preclinically depressed elderly people may
return to normal if detected early and treated adequately, they must
be identiﬁed in the community. Therefore, a large-scale studycy & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
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gation of awide range of common comorbidities that inﬂuencing the
occurrence of depression among elderly people in developing
countries, such as Malaysia, is needed.
Secondly, few depression studies report the nutritional status of
elderly people and most utilized a single nutritional assessment to
deﬁne malnutrition7. Meanwhile, another study reported that
malnourished elderly people have a higher incidence of depression
than the well-nourished8. However, one recent study revealed that
depressed women aged 65 and older have higher serum vitamin
B12 levels compared with nondepressed women9. The inconsis-
tency of these results warrant a more complete assessment of
nutritional status that utilizes basic anthropometric measure-
ments, nutritional intake assessments, and biochemical analyses to
better examine the inﬂuences of these parameters on depressive
symptoms in the elderly.
Third, although studies have concluded that depressed geriat-
rics had cognitive impairments, by assessing memory capabilities
or global cognitive functioning using the Mini-Mental State
Examination (MMSE)10, most prior research has not investigated
which cognitive domains are exaggerated in depression. In fact, the
extent of cognitive impairment among the depressed elderly may
not only apply to single-domain impairments. Broader cognitive
function assessments, which look into different cognitive domains,
warrant better understanding of the cognitive manifestations in
depression. Nevertheless, a very recent study revealed that there
are no signiﬁcant differences in overall cognitive performance
between depressed and normal geriatrics3.
The shortcomings of previous research and inconsistent ﬁnd-
ings led us to re-examine and expand the current understanding of
depression symptoms in the elderly. Thus, the objectives of the
present study were: (1) to examine the prevalence of depression
and its risk factors; (2) to describe and compare the presence of
comorbidities among depressed and nondepressed elderly people;
(3) to evaluate and compare the nutritional status of these two
groups; and (4) to investigate which cognitive domains are exac-
erbated among depressed geriatrics, and to determine if indeed this
exists, in a community-dwelling population.
2. Materials and methods
2.1. Recruitment of subjects
This cross-sectional study was conducted at 15 low-cost public
residential buildings around Zone I of the Cheras area in the
metropolitan city of Kuala Lumpur, during the period from
November 2008 to May 2009. These low-cost residential buildings
were built separately at different times (1975e2001). Multiple
strategies were implemented to recruit subjects. This involved
formal invitation via letter, a direct house-to-house approach,
banner advertisement at the building entrance, and informal invi-
tation by local community representatives. The inclusion criteria
were elderly people aged 60 years and over, either Malay or
Chinese, with no documented history of mental illness or psychi-
atric disorders, and who were able to communicate. More details
on the recruitment of subjects were published elsewhere11. The
study was approved by the medical research secretariat, Universiti
KebangsaanMalaysiaMedical Centre and all subjects signed inform
consent prior to participation in this study.
2.2. Baseline characteristics
The subject’s demographic details were obtained via face-to-
face interviews using a standard questionnaire. The questionnaire
acquired details such as gender, race, age, marital status, andeducation. Information such as employment status, exercise prac-
tices, living arrangement, ﬁnancial satisfaction, social engagement,
and alcohol and drug use were also gathered.
2.3. Measurement of depressive symptoms
Depressive symptoms were assessed by clinical psychologists
using a shortened version of the Geriatric Depression Scale (GDS)12.
The sensitivity of GDS-15 is 0.94013, while the speciﬁcity is 0.87014.
The subjects were asked independently and the answers were
recorded as “yes” or “no”. In this study, a GDS score 5 was used as
an indication of depressive symptoms.
2.4. Comorbid variables
We also recorded the presence of any comorbid conditions in
each subject based on medical records established before or at
recruitment; these were extensively review for any documented
evidence of disorders. A total of 13 types of comorbid medical
conditions were reported, including type 2 diabetes mellitus,
hypertension, heart disease, respiratory disease, gastrointestinal
disease, rheumatoid arthritis, urological disease, visual impairment,
hearing impairment, hypercholesterolemia, hypertriglyceridemia,
hyperlipidemia, and hyperhomocysteinemia.
2.5. Clinical and laboratory examinations
A total of 20mL of fasting peripheral venous blood was collected,
centrifuged at 3000 rpm, and stored at -80

C for analyses within 3
months after collection. Serum total cholesterol and triglycerides
weremeasuredwith the use of anenzymatic assayonanADVIA2400
chemistry system (Siemans Healthcare Diagnostics, United States),
while serum homocysteinewasmeasured by the utilization of direct
chemiluminescent technology using an ADVIA Centaur (Siemans
Healthcare Diagnostics). Hypercholesterolemia (serum cholesterol
levels > 5.2 mmol/L), hypertriglyceridemia (serum triglyceride
levels > 1.68 mmol/L) and hyperlipidemia (serum low-density
lipoprotein cholesterol levels > 2.58 mmol/L) were also diag-
nosed15. Hyperhomocysteinemia was deﬁned as a serum homo-
cysteine level > 20 mmol/L, parallel to the standard deﬁnition for
hyperhomocysteinemia determined by international consensus16.
2.6. Nutritional assessments
Anthropometric measurements were assessed by trained ﬁeld
workers. Standing height and body weight were measured when
the patients was in light clothing (without shoes) to the nearest 0.1
kg. Body mass index (BMI) was calculated using the body weight in
kilograms divided by the square of the standing height in meters.
Waist circumference (WC) was measured using a nonelastic
measuring tape.
Nutrient intakes information for the past week was obtained at
an individual interview using a structured, validated dietary history
questionnaire administered by trained dieticians or nutritionists17.
The interview session was complemented by the use of food atlas,
food model, and household utensils to assist subjects to recognize
the exact food sources and portion sizes. Dietary data were entered
and processed using the Foodworks nutrient analysis software
package (version 3.02; Xyris Software)18 and compared with the
recommended nutrient intake for Malaysians19.
Biological indicators of nutritional status were also recorded in
the studied population. The ADVIA Centaur (Siemens Healthcare
Diagnostics) direct chemiluminescent technology immunoassay
was used to determine serum cobalamin and red blood cell folate
concentrations within 3 hours. Meanwhile, vitamin A (serum
L.K. Lee et al.280retinol) and vitamin E (plasma alpha tocopherol) status were
determined using high-performance liquid chromatography
(HPLC) (Hewlett, United States)20 using a diode array detector
under UV light at 325 and 295 nm, respectively within 6 months.
2.7. Neuropsychological measures
A neuropsychological battery was designed as a brief and
comprehensive way to assess global cognitive function, dementia
status, new verbal learning and memory, short-term memory and
attention, visuoconstruction, and abstract-thinking skills. The
MMSE21 was administered as a measure of global cognitive func-
tion. Dementia Rating Scale (DRS)22 was used as the dementia
screening tool. Rey Auditory Verbal Learning Test (RAVLT)23 was
included as the test of new verbal learning and memory. The total
number of words learned in ﬁve trials (total immediate recall) and
delayed recall (following a 15-minute delay) were also examined.
Short-term memory and attention were assessed using the Digit
Span subtest of the Wechsler Adult Intelligence Scale (WAIS-III)24.Table 1
Univariate association between depressed and nondepressed elderly.*
Variable Total (n ¼ 318) Depressed elderly (n ¼96
n % n %
Gender
Men 130 40.9 35 26
Women 188 59.1 61 32
Race
Malay 239 75.2 67 28
Chinese 79 24.8 29 36
Age group
60 e 74 y 296 93.1 86 29
75 y 22 6.9 10 45
Marital status
Single/Divorced/Widower 115 36.2 42 36
Married 203 63.8 54 26
Living arrangement
Alone 18 5.7 3 16
With spouse/children/others 300 94.3 93 31
Financial satisfaction
Yes 278 87.4 81 29
No 40 12.6 15 37
Years of education
6 y 228 71.7 72 31
7 y 90 28.3 24 26
Employment status
Employed 38 11.9 9 23
Unemployed 280 88.1 87 31
Social engagement
Yes 144 45.3 34 23
No 174 54.7 62 35
Exercise
Yes 119 37.4 24 20
No 199 62.6 72 36
Smoking
yes 51 16.0 13 25
no 267 84.0 83 31
Alcohol drinking
Yes 8 2.5 2 25
No 310 97.5 94 30
Taking drug
Yes 190 59.7 59 61
No 128 40.3 37 38
CI ¼ conﬁdence interval.
* Chi-square test.Visuoconstruction and abstract-thinking skills were measured
using the Clock Drawing Test (CDT)25. All neuropsychological
measures were administered and scored in accordance with pub-
lished protocols.
2.8. Statistical analyses
The prevalence of depressive symptomatology and comorbidity
proﬁles were estimated as frequencies and percentages. Group
comparisons of the categorical data according to depression status
were analysed using c2 test and reported as 2  2 tabulation tables.
Binary logistic regression was used to simultaneously determine
the relative predictors of depressive symptoms. Nutritional
assessments and neuropsychological test scores between groups
were calculated as the mean and standard deviation using the
independent t test or generalized linear model. Two-sided p
value < 0.05 was used to indicate statistical signiﬁcance, while all
statistical analyses were conducted using SPSS for Windows
(version 17.0; SPSS Inc., Chicago, IL, United States).) Nondepressed elderly (n ¼ 222) Odds ratio (95% CI) p
n %
.9 95 73.1 1.304 (0.796 e 2.135) 0.292
.4 127 67.6
.0 172 72.0 1.489 (0.870 e 2.549) 0.147
.7 50 63.3
.1 210 70.9 2.035 (0.847 e 4.886) 0.112
.5 12 54.5
.5 73 63.5 1.588 (0.972 e 2.594) 0.065
.6 149 73.4
.7 15 83.3 2.246 (0.635 e 7.947) 0.209
.0 207 69.0
.7 197 70.3 1.459 (0.732 e 2.911) 0.283
.5 25 62.5
.6 156 68.4 1.269 (0.736 e 2.187) 0.391
.7 66 73.3
.7 29 76.3 1.453 (0.660 e 3.199) 0.354
.1 193 68.9
.6 110 76.4 1.791 (1.093 e 2.936) 0.021
.6 112 64.4
.2 95 79.8 2.244 (1.317 e 3.824) 0.003
.2 127 63.8
.5 38 74.5 0.758 (0.384 e 1.498) 0.426
.1 184 68.9
.0 6 75.0 0.766 (0.152 e 3.865) 0.747
.3 216 69.7
.5 131 59.0 1.108 (0.678 e 1.809) 0.683
.5 91 41.0
Table 2
Association with depressive symptoms.
Predictor Adjusted OR 95% CI b p*
Chinese 1.329 0.698 e 2.530 0.284 0.387
Older age ( 75 y) 1.686 0.503 e 5.649 0.522 0.397
Married 0.683 0.377 e 1.237 0.381 0.209
No social network 1.511 0.872 e 2.615 0.412 0.141
No habitual exercise 2.163 1.236 e 3.788 0.772 0.007
OR ¼ odds ratio.
* Binary logistic regression analysis: adjusted for age and gender.
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3.1. Baseline characteristics
Out of the 318 geriatricswhowere interviewed,130 (40.9%)were
men and 188 (59.1%) were women. The mean ( SD) age was
65.95.3 years, ofwhich75.2%wereMalays (Table 1).Most subjects
had only attained low levels of education (71.7%), and 63.8% subjects
weremarried. The majority of the subjects were satisﬁed with their
ﬁnancial status (87.4%) and lived under one roofwith family (94.3%).
Most subjects reported a lack of social interactions and habitual
exercise (54.7% and 62.6%), while small proportions were identiﬁed
as smokers (16.0%) and alcohol drinkers (2.5%). Approximately 60%
subjects consumed some sort of drug on a daily basis.
3.2. Prevalence of depressive symptoms according to
measured variables
Table 1 illustrated the frequency of depressive subjects,
including their characteristics proportionate to various indepen-
dent categorical variables. A total of 30.2% of subjects (26.9% of men
and 32.4% of women) suffered from depressive symptoms. Subjects
aged 75 years and above were twice as likely to be affected by
depressive symptoms than young geriatrics; however, this ﬁnding
was not statistically signiﬁcant. Univariate analysis also revealed
a signiﬁcant association between depressive symptoms and social
engagement, with a higher prevalence (35.6%) among those
without social networks (odds ratio [OR] ¼ 1.791; 95% conﬁdence
interval [CI] ¼ 1.093e2.936; p < 0.05) compared with those with
engaged social networks (23.6%). Meanwhile, subjects with
depressive symptoms weremore likely to be not engage in habitual
exercise (OR ¼ 2.244; 95% CI ¼ 1.317e3.824; p < 0.01) compared
with nondepressed individuals. However, depressive symptoms
were best predicted by the lack of regular exercise only after
adjusting for gender and age (adjusted OR ¼ 2.163; 95%
CI ¼ 1.236e3.788; p < 0.01) (Table 2).Table 3
Comparison between the comorbidity status of depressed and nondepressed elderly.*
Variables Non-depressed (n ¼ 222) Depre
n % n
Type 2 Diabetes mellitus 96 43.2 43
Hypertension 119 53.6 46
Heart disease 17 7.7 10
Respiratory disease 19 8.6 5
Gastrointestinal disease 28 12.6 15
Rheumatoid arthritis 92 41.4 49
Urology disease 16 7.2 5
Visual impairment 135 60.8 50
Hearing impairment 9 4.1 8
Hypercholesterolemia 153 73.9 62
Hypertriglyceridemia 69 33.3 21
Hyperlipidemia 186 89.9 80
Hyperhomocysteinemia 82 39.6 38
CI ¼ conﬁdence interval.
* Chi-square test.3.3. Comparison of comorbid conditions between nondepressed and
depressed geriatrics
The prevalence of comorbid conditions was not signiﬁcantly
different between the depressed and nondepressed groups (p
> 0.05) (Table 3). Overall, the prevalence of hyperlipidemia (90.9%
in the depressed group; 89.9% in the nondepressed group) was the
highest compared to other types of comorbid conditions. Also, the
present study showed a two-fold higher prevalence of hearing
impairment among the depressed elderly, although the 4.2%
intergroup difference did not reach statistical signiﬁcance.
3.4. Nutritional proﬁles comparing nondepressed and
depressed elderly
A similar trend was observed for nutritional status, of which no
signiﬁcant difference was found between the two groups in terms
of nutritional intake, anthropometric measurement, or any of the
various biochemical analyses (Table 4). Nonetheless, overall, men
had signiﬁcantly higher intakes of energy (p < 0.0001), carbohy-
drates (p < 0.0001), fat (p < 0.0001), protein (p < 0.0001), iron
(p < 0.01), and niacin (p < 0.0001) and had a wider waist circum-
ference (p < 0.05) compared to women. Meanwhile, women had
higher plasma vitamin E concentrations (p < 0.05) compared to
men, regardless of depression status.
3.5. Neuropsychological assessments comparing nondepressed and
depressed elderly
For all subjects, WAIS-R equivalent scores were assigned by
converting raw WAIS-III scores, which were uncorrected for
demographic factors, to scaled scores for the WAIS-R standardiza-
tion sample. Without adjustment, the examination revealed that
subjects with depressive symptoms had lower scores on almost all
cognitive tests compared to nondepressed subjects (Table 5).
However, the signiﬁcant differences were limited to the MMSE
(F ¼ 4.740; p < 0.05) and RAVLT total immediate recall (F ¼ 4.113;
p < 0.05) only after adjusted for age, gender, ethnicity, and total
years of schooling. On the contrary, no signiﬁcant performance
difference was found between the two groups on the CDT, DRS,
digit span, or RAVLT delayed-recall subtests.
4. Discussion
The prevalence of depressive symptoms among elderly people
from low-income households in a metropolitan city measured inssed (n ¼ 96) 95% CI Odds ratio p
%
44.8 0.658 e 1.724 1.065 0.798
47.9 0.493 e 1.286 0.796 0.352
10.4 0.617 e 3.186 1.402 0.419
5.2 0.213 e 1.621 0.587 0.299
15.6 0.651 e 2.529 1.283 0.472
51.0 0.911 e 2.383 1.473 0.114
5.2 0.252 e 1.990 0.512 0.707
52.1 0.432 e 1.135 0.700 0.148
8.3 0.804 e 5.757 2.152 0.127
70.5 0.484 e 1.463 0.842 0.541
23.9 0.355 e 1.107 0.627 0.108
90.9 0.480 e 2.656 1.129 0.781
43.2 0.699 e 1.921 1.159 0.568
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Table 5
Neuropsychological performances of depressed and nondepressed elderly.*
Neuropsychological
tests
Nondepressed
(n ¼ 222)
Mean  SD
Depressed
(n ¼ 96)
Mean  SD
F statistic p
MMSE 24.1  4.4 22.4  4.9 4.740 0.030
DRS 121.4  15.3 115.8  19.3 2.883 0.091
CDT 6.1  2.4 5.6  2.6 0.888 0.347
GDS 2.1  1.3 6.4  1.9 568.293 <0.0001
Digit spany 7.7  2.5 8.0  2.5 2.080 0.150
RAVLT total learning 29.4  9.7 26.2  10.0 4.113 0.043
RAVLT delayed learning 4.2  3.5 3.2  3.2 2.923 0.088
MMSE ¼ Mini-Mental State Examination; DRS ¼ Dementia Rating Scale;
CDT¼ Clock Drawing Test; GDS¼ Geriatric Depression Scale; RAVLT¼ Rey Auditory
Verbal Learning Test.
* Generalized linear model: adjusted for age, gender, ethnicity and total years of
schooling.
y scaled score of digit span forward and digit span backward.
L.K. Lee et al.282this study was almost triple that of the psychiatric morbidity
(11.2%) reported among Malaysian adults26. Nevertheless, the
prevalence was consistent with a previous Egyptian study (32.1%)
on diabetic outpatients27, but remarkably higher compared to
geriatric outpatients in Turkey (21.8%)28 and community-dwelling
elderly persons in Brazil (24.3%)8. This may be due in part to the
fact that different study designs (e.g., inpatient vs. community
setting) affect the selection of depression scales and, thus, inﬂuence
the overall outcomes. Meanwhile, in the Netherlands, 26.1% of the
elderly was found to have depression using serial measurements of
depression29, while the rate of depression based on general practi-
tioners’ assessments was only 8.2%6. Hence, future research should
clarify the reliability of a wide range of depression scales according
to the study design, as this may help to reduce systematic bias.
The present study also found that subjects who led an inactive
lifestyle had double the risk of developing depressive symptoms
compared with those who engaged in regular exercise. A recent
longitudinal study also reported the preventive role of leisure time
and physical activity in depression30. Physical activities inﬂuence
central monoamine functioning and stimulate endorphin levels31
and increase self-esteem32, thus reducing depression. However,
cross-sectional analyses indicate that it is also possible that
depressed subjects are not motivated to exercise. Meta-analyses
highlighted that exercise and physical activity can improve
mental well-being in older people, especially when using a group-
based approach led by trained leaders33.
Studies have reported that depressive symptoms are prevalent
among the diabetic elderly34, while a community-based Danish
cohort of men and womenwho were followed for 27 years showed
that depressed patients are also at increased risk of myocardial
infarction35. We believe that depressive symptoms are not speciﬁc
to a particular type of disorder but are general to all people and can
be very serious and disabling. In fact, divergence between reports in
different clinical settings and community-based epidemiologic
studies exist, where speciﬁc physical illnesses have been carefully
deﬁned and diagnosed among psychiatric inpatients and outpa-
tients, while community-based epidemiological study were
considerably more representative of the nature and magnitude of
the observed physical illness-psychiatric disorder relationships that
can be generalized to other populations36. The disparities of this
study’s ﬁndings on comorbidity with other studies could be due to
the high prevalence of comorbidity proﬁles among the subjects.
Thus, the subjects were rather homogenous with respect to
comorbidity. In order to investigate the relationship between
comorbidity and depressive symptoms, a prospective or time-
series study should be employed.
No single nutritional assessment conducted in this study could
ﬁnd a correlation with depressive symptoms. The ﬁnding is in
Comorbidities, Nutritional Status and Neuropsychological Performance 283agreement with previous studies37,38. On the contrary, Saka et al
(2010) reported that depressive elderly who were admitted to
geriatric outpatient clinics showed poor nutritional status according
to theMini Nutritional Assessment (MNA)7. The same screening tool
was applied in a cross-sectional study in southern Brazil, and the
results indicate that nutritional deﬁcits in the elderly are indepen-
dently associated with depression8. Besides, Nanri et al (2010)
suggested that low serum folate is related to the increased preva-
lence of depressive symptoms among Japanese men39. The incon-
sistent ﬁndings could be attributed to the complex complications of
health status, psychosocial difﬁculties, and cognitive impairments
that affect nutritional parameters.
Our study conﬁrms that depression modulates the cognitive
impairments of older adults in the context of global cognitive
functioning and immediate verbal learning ability. This ﬁnding
provides support for and extends previous research that yielded
similar results40. This indirectly suggests that depression in the
elderly reﬂects a speciﬁc component of the disabilities that are
related to dementia. A recent study conﬁdently showed that the
ability to acquire and recall new verbal information over several
consecutive trials is poorer among the depressed elderly41, sug-
gesting that several cognitive domains, including immediate
memory, efﬁciency of learning, retention, and subjective organi-
zation, are deteriorated among the depressed elderly. Interestingly,
in our study, other measures of executive function, such as atten-
tion, psychomotor speed, visuoconstruction, and abstract-thinking
skills, were not affected in depressed group, indicating that such
cognitive domains are preserved among depressed subjects and
that they can perform daily living activities. Nevertheless, our study
contradicts the ﬁndings of a previous study, namely that depression
does not worsen cognitive impairment beyond the effect of
dementia itself42. This mainly hinges on the variety and sensitiv-
ities of the cognitive tools used to compare depressive and non-
depressive elderly. The present study clearly shows that both
MMSE and RAVLT are capable of detecting differences in the
cognitive proﬁles of depressed and nondepressed elderly.
According to Ohta et al (2008), persistent cognitive impairment
in depressed persons can be interpreted as a consequence of
affected functional networks in the prefrontal brain structures and
hippocampus43. These functional alterations may partly be
explained by dysregulation of the hypothalamic-pituitary-
adrenocortical (HPA) system, resulting in hypercortisolemia44.
Consequently, elevated glucocorticoid levels may have a detri-
mental effect on the hippocampus, through inhibition of long-term
potentiating and dendritic atrophy of the hippocampal neurons.
Since the hippocampus is prominently involved in memory func-
tions, memory impairment may be linked to hypercortisolism45.
Besides, signiﬁcant research has concluded that depleted mono-
amine neurotransmitters may be involved in the pathogenesis of
depression. Depleting the production of serotonin by serotonergic
neurons results in the dysregulation of many important physio-
logical functions, including sleep, aggression, eating, sexual
behavior, and mood. In the same vein, the "catecholamine
hypothesis" also suggests that a deﬁciency in norepinephrine is
responsible for depression46.
From a hereditary perspective, meta-analysis of ﬁve large and
rigorously selected family studies on major depression found
evidence of familiarity in this disease, namely a relative risk of 2.8
for affected subjects with ﬁrst-degree relatives also afﬂicted with
depression47. Estimates from twin studies have consistently
demonstrated that genetic factors contribute 40e60% of the vari-
ance in neuroticism and other related personality traits48. Inter-
estingly, a reduced estrogen concentration can alter serotonergic
activities, thereby playing a major role in depression in women
undergoing menopause. The suggestion was proposed thatestrogen therapy is an appropriate treatment for mild-to-moderate
depression in peri- and postmenopausal women49.
Notably, in this study, we could not detect the age of onset of
depression as a distinguishing clinical characteristic. It would be
more valuable to classify early-onset depression (EOD) and late-
onset depression (LOD) among elderly individuals, as these
different groups of people may present extremely different func-
tional, physiological, and neurological brain abnormalities and
psychological entities. It should be noted that ﬁndings from a cross-
sectional study, such as the present study, could not be generalized
to other clinical and outpatient settings, and vice versa. However,
longitudinal studies should be carried out to follow those elderly
with depressive symptoms in order to prevent transition to severe
or persistent depression states. Another limitation is that our
neuropsychological battery of tests was not capable of assessing
a comprehensive aspect of cognitive function, although we were
able to draw on a range of tests that incorporated cognitive domain
abilities. Nevertheless, the present work has several strengths. Our
study pinpointed a new way to investigate the inﬂuence of a wide
spectrum of comorbid conditions and nutritional status measure-
ments that might differentiate the incidence of depressive symp-
toms among elderly people. Moreover, we adopted a combination of
nutrient intake assessment, anthropometric measurements, and
biochemical indicators to measure nutritional status, thus capturing
the overall picture of the parameters that inﬂuence depression.
In summary, our data reveal that one-third of the studied pop-
ulation had depressive symptoms, notably those who were not
engaged in regular exercise. Comorbid conditions and nutritional
status were not associated with the occurrence of depressive
symptoms. Depressed elderly persons presented worse cognitive
impairments, notably global cognitive function and verbal imme-
diate learning and memory. Hence, it might be worthwhile to plan
for further psychosocial and cognition-enhancing interventions
that target high-risk elderly persons. The need for additional work
aimed at identifying more sensitive measurements and approaches
that can be used across clinical and epidemiological studies is
compelling.
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